You just read:

EIP Pharma announces upcoming oral presentations of Phase 2a clinical trial results with neflamapimod (VX-745) at Clinical Trials in Alzheimer's Disease (CTAD) conference Dec 8-10, 2016

News provided by

EIP Pharma LLC

Nov 16, 2016, 08:00 ET